TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cochlear ( (AU:COH) ) just unveiled an announcement.
Cochlear Limited announced the issuance of unquoted equity securities under its employee incentive scheme, which includes options and performance rights. This move is part of the company’s strategy to incentivize employees and align their interests with the company’s growth objectives, potentially impacting its operational dynamics and market positioning.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$312.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company is known for its cochlear implants and other hearing devices, focusing on improving the quality of life for individuals with hearing loss.
Average Trading Volume: 135,625
Technical Sentiment Signal: Buy
Current Market Cap: A$18.56B
For an in-depth examination of COH stock, go to TipRanks’ Overview page.